Paying for CAR-T Therapy Amidst Limited Health System Resources

J Clin Oncol. 2019 Aug 20;37(24):2095-2097. doi: 10.1200/JCO.19.01113. Epub 2019 Jun 3.

Authors

Jonathan D Campbell¹, Melanie D Whittington¹

Affiliation

¹ 1University of Colorado Anschutz Medical Campus, Aurora, CO.

PMID: 31157580
DOI: 10.1200/JCO.19.01113

No abstract available

Publication types

Comment

MeSH terms

Cell- and Tissue-Based Therapy
Cost-Benefit Analysis
Humans
Immunotherapy, Adoptive
Lymphoma, B-Cell*
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen*

Substances

Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen